Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 11:05 am Sale | 13G | GTY TECHNOLOGY HLDGS INC GTYH | UBS OCONNOR LLC | 758,000 1.32% | -4,655,674 (-86.00%) | View |
| 2022-02-14 10:59 am Sale | 13G | GREENSKY INC GSKY | UBS OCONNOR LLC | 698,553 0.76% | -6,255,302 (-89.95%) | View |
| 2022-02-14 10:52 am Purchase | 13G | GESHER I ACQUISITION CORP SHS GIAC | UBS OCONNOR LLC | 1,021,225 7.01% | 1,021,225 (New Position) | View |
| 2022-02-14 10:46 am Purchase | 13G | FAR PEAK ACQUISITION CORP FPAC | UBS OCONNOR LLC | 3,886,068 5.57% | 3,886,068 (New Position) | View |
| 2022-02-14 10:41 am Unchanged | 13G | SHARECARE, INC. CLASS SHCR | UBS OCONNOR LLC | 0 0% | 0 (Unchanged) | View |
| 2022-02-14 10:37 am Purchase | 13G | CONYERS PK III ACQ CORP COM CL CPAA | UBS OCONNOR LLC | 3,205,991 7.18% | 3,205,991 (New Position) | View |
| 2022-02-14 10:34 am Sale | 13G | AMRYT PHARMA PLC SPONSORED ADR AMYT | UBS OCONNOR LLC | 9,950,000 3.11% | -3,263,340 (-24.70%) | View |
| 2022-02-14 10:29 am Unchanged | 13G | JASPER THERAPEUTICS INC JSPR | UBS OCONNOR LLC | 0 0% | 0 (Unchanged) | View |
| 2022-02-14 10:26 am Purchase | 13G | ALPHA HEALTHCARE ACQUISITION C ALPA | UBS OCONNOR LLC | 1,485,000 7.51% | 1,485,000 (New Position) | View |
| 2022-02-14 10:21 am Purchase | 13G | AFTERNEXT HEALTHTECH ACQUISITI AFTR | UBS OCONNOR LLC | 1,557,405 6.23% | 1,557,405 (New Position) | View |
| 2022-02-14 10:16 am Sale | 13G | ACORDA THERAPEUTICS INC ACOR | UBS OCONNOR LLC | 0 0% | -5,323,234 (Position Closed) | View |
| 2022-02-14 10:09 am Purchase | 13G | EVOLV TECHNOLOGIES HLDGS INC C EVLV | UBS OCONNOR LLC | 1,547,311 1.09% | 1,547,311 (New Position) | View |
| 2021-02-16 10:41 am Purchase | 13G | ACORDA THERAPEUTICS INC ACOR | UBS OCONNOR LLC | 5,323,234 9.99% | 5,323,234 (New Position) | View |
| 2021-02-16 10:39 am Purchase | 13G | Teligent Inc. TLGT | UBS OCONNOR LLC | 2,000,001 8.4% | 2,000,001 (New Position) | View |
| 2021-02-16 10:37 am Purchase | 13G | SHIFT TECHNOLOGIES INC SFT | UBS OCONNOR LLC | 56,251 0.1% | 56,251 (New Position) | View |
| 2021-02-16 10:35 am Purchase | 13G | PARTS ID INC ID | UBS OCONNOR LLC | 164,703 0.5% | 164,703 (New Position) | View |
| 2021-02-16 10:34 am Purchase | 13G | SOC TELEMED INC CORP TLMD | UBS OCONNOR LLC | 1,250,000 1.6% | 1,250,000 (New Position) | View |
| 2021-02-16 10:32 am Purchase | 13G | AMRYT PHARMA PLC SPONSORED ADR AMYT | UBS OCONNOR LLC | 13,213,340 7.3% | 13,213,340 (New Position) | View |
| 2021-02-16 10:30 am Purchase | 13G | GREENSKY INC GSKY | UBS OCONNOR LLC | 6,953,855 9.1% | 6,953,855 (New Position) | View |
| 2021-02-16 10:27 am Purchase | 13G | FALCON CAP ACQUISITION CORP CL FCAC | UBS OCONNOR LLC | 2,970,000 8.6% | 2,970,000 (New Position) | View |